FOR IMMEDIATE RELEASE

Hobart, WI – October 9, 2025 – The Center for Research and Analysis of VAscular Tumors (CRAVAT) Foundation has donated its resources to The EHE Foundation in a powerful alignment of vision and commitment to the people affected by epithelioid hemangioendothelioma (EHE) and the EHE scientific community. 

Founded in 2015 by Guy and Mary Weinberg, CRAVAT has provided support to those affected by EHE, raised awareness, funded basic research, supported scientific conferences related to EHE, and contributed to the development of potential treatments over the past decade. The EHE Foundation is honored to have the trust of the CRAVAT Foundation and carry forward shared goals of patient support, global advocacy, and critical research into treatments for EHE. Dr. Guy Weinberg continues to serve the EHE community as a member of The EHE Foundation’s Board of Directors, where his invaluable leadership will help guide the future of EHE research.

“The EHE Foundation is indebted to Guy and Mary Weinberg for their vision and for placing their trust in The EHE Foundation. We are eternally grateful to long-standing CRAVAT Foundation supporters and collaborators, and we stand committed to the vision and legacy of this invaluable organization. Together, we are stronger and acutely focused on tackling this ultra-rare disease.” 
~ Denise Robinson, Executive Director, The EHE Foundation

“I am thrilled to join the EHE Foundation and help advance our shared goals of supporting the EHE community and finding a cure for this disease. ”
~ Guy Weinberg, MD, Founder, CRAVAT Foundation

About epithelioid hemangioendothelioma (EHE)

EHE is an ultra-rare vascular sarcoma that has a prevalence of less than one in a million people, affecting all age groups, and is very rare in children. With an unpredictable clinical course, this rare cancer can arise anywhere in the body, most commonly occurring in the liver, lungs, and bones, with more than 50% of patients presenting with metastatic disease.

About The EHE Foundation

The EHE Foundation is the leading global nonprofit advocacy and research organization dedicated to finding treatments and a cure for epithelioid hemangioendothelioma (EHE), an ultra-rare vascular cancer. We connect patients, researchers, clinicians, and industry to drive scientific progress, advance research, and improve the lives of people diagnosed with EHE. Through aggressive funding, strategic collaboration, and patient education, we accelerate research, empower those affected, and work toward finding treatments—and ultimately, a cure.

For more information, contact [email protected].

###